Furthermore, the higher levels of insulin and C-peptide observed in the patient group may be explained by the presence of hyperglycemia and type 2 diabetes in this group, as well as a higher prevalence of obesity and central obesity, which are commonly associated with increased insulin resistance. The gene discussed is INS; the disease is Abdominal obesity.